Lake Forest-based Orqis Medical, which is developing therapies for treating congestive heart failure, said that it has raised $12M in the second close of its Series D round of financing. The funding brings the company's Series D total to $34.7M. Investors in the round included Wasatch Advisors, Cross Creek Capital, and the Omega Fund, along with existing investors. More information »